| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 179,867 |
-
| | Cost of Revenue | 199,163 |
-
| | | Gross Profit | (19,296) |
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 18,394 | 9,215 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (37,690) | (9,215) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (40,606) | 1,812 | | Earnings Before Interest And Taxes | (78,296) | (2,421) | | Interest Expense | 5,831 |
-
| | Income Before Tax | (84,127) | (2,421) | | Income Tax Expense |
-
|
-
| | Minority Interest | 43,262 | 4,982 | | | | Net Income From Continuing Ops | (40,865) | (2,421) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (40,865) | (2,421) | | Preferred Stock And Other Adjustments |
-
| (1,327) | | | Net Income Applicable To Common Shares | ($40,865) | ($3,748) |
|
0.63% Nasdaq 
0.03%
Income Statement
